16:26
Addressing the Business Side of GLP-1 Manufacturing
34:03
Advancing Hematology and Cell Therapy Innovation with AstraZeneca's Aliya Omer
44:17
Investing in Impact: Targeting Duchenne Muscular Dystrophy with Gene Editing Precision
47:53
Navigating The Complexity of Conditionally Active Biologics With Bonum Therapeutics
35:17